Gosse Bruinsma, a medical doctor and veteran life science executive, has been appointed chief executive and chairman of IDEA AG, a privately-held biopharmaceutical company in Munich, Germany. The company develops and commercialises non-invasive, targeted therapeutics delivered through the skin. Dr Bruinsma replaces Gregor Cevc who has left the company.
Copyright 2010 Evernow Publishing Ltd